Postoperative Analgesia in Abdominal Surgery: a Medico-economic Study

NCT ID: NCT01470846

Last Updated: 2014-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background : Epidural anaesthesia is associated in abdominal surgery with reduced pain and postoperative respiratory complications together with quicker recovery of bowel function. Currently, no studies have been able to prove its ability to reduce length of stay in intensive care and high-dependency units.

Purpose : The aim of this study is to demonstrate that epidural anaesthesia reduces length of stay in intensive care unit after abdominal surgery under laparotomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There are currently two methods of analgesia in postoperative abdominal surgery : patient-controlled analgesia (PCA) with opioids and epidural analgesia.

No international recommendations regarding the use of either of these techniques have yet been written. Epidural analgesia is superior to intravenous morphine, including during mobilization and coughing. It also reduces respiratory complications and optimizes postoperative rehabilitation. Nevertheless, mortality is not improved with this technique. Few publications exist on the optimization of the duration of hospitalization in the intensive care unit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Extended Ileal Resection Under Laparotomy Total Proctocolectomy Under Laparotomy Colectomy Left/Right/Total Under Laparotomy Rectosigmoidal Resection Under Laparotomy Anterior Resection of Rectum Under Laparotomy Abdomino-perineal Amputation Under Laparotomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

APD

patient with epidural analgesia

Group Type EXPERIMENTAL

epidural analgesia

Intervention Type PROCEDURE

thoracic position (T8-T9 or T11-T12) depending on the site of surgery

PCA

Patient with morphine analgesia

Group Type ACTIVE_COMPARATOR

PCA

Intervention Type PROCEDURE

Morphine 2 mg / 10 min (no max dose) + droperidol 2.5 mg / 50 mL.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

epidural analgesia

thoracic position (T8-T9 or T11-T12) depending on the site of surgery

Intervention Type PROCEDURE

PCA

Morphine 2 mg / 10 min (no max dose) + droperidol 2.5 mg / 50 mL.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Surgery scheduled under laparotomy
* Extended ileal resection
* Total proctocolectomy
* Colectomy left/right/total
* Rectosigmoidal resection
* Anterior resection of rectum
* Abdomino-perineal amputation
* Adult patient
* Written consent obtained
* Planned hospitalization in the intensive care unit
* Patient affiliated to social security

Exclusion Criteria

* Patients inapt to give consent
* Emergency surgery
* Contraindication to epidural analgesia
* Contraindication to levobupivacaïne, morphine or sufentanil
* Dementia
* Participation in another research protocol
* Pregnancy or breastfeeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Limoges

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nathalie NATHAN-DENIZOT, MD

Role: PRINCIPAL_INVESTIGATOR

Limoges UH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Limoges - Service d'anesthésie-réanimation

Limoges, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I10030 PERIDIGE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.